ArticleInternational journal of oncology2022

MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway.

Jiecheng Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.